SG Americas Securities LLC lessened its holdings in shares of Xylem Inc. (NYSE:XYL – Free Report) by 68.2% in the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 37,359 shares of the industrial products company’s stock after selling 80,278 shares during the quarter. SG Americas Securities LLC’s holdings in Xylem were worth $5,510,000 at the end of the most recent reporting period.
Other large investors have also recently modified their holdings of the company. AQR Capital Management LLC lifted its stake in shares of Xylem by 14.4% during the 1st quarter. AQR Capital Management LLC now owns 30,955 shares of the industrial products company’s stock valued at $3,645,000 after buying an additional 3,900 shares in the last quarter. NewEdge Advisors LLC grew its stake in Xylem by 3.3% in the 1st quarter. NewEdge Advisors LLC now owns 4,151 shares of the industrial products company’s stock valued at $496,000 after buying an additional 132 shares in the last quarter. Empowered Funds LLC raised its holdings in Xylem by 56.1% during the 1st quarter. Empowered Funds LLC now owns 8,678 shares of the industrial products company’s stock valued at $1,037,000 after acquiring an additional 3,120 shares during the period. Focus Partners Wealth lifted its position in shares of Xylem by 217.4% during the first quarter. Focus Partners Wealth now owns 59,608 shares of the industrial products company’s stock worth $7,121,000 after acquiring an additional 40,827 shares in the last quarter. Finally, Strs Ohio purchased a new stake in shares of Xylem during the first quarter worth $10,781,000. Hedge funds and other institutional investors own 87.96% of the company’s stock.
Xylem Stock Performance
NYSE:XYL opened at $139.62 on Friday. The stock has a market cap of $33.99 billion, a P/E ratio of 35.89, a PEG ratio of 1.98 and a beta of 1.17. The company has a quick ratio of 1.50, a current ratio of 1.96 and a debt-to-equity ratio of 0.17. The business’s 50-day moving average price is $141.08 and its two-hundred day moving average price is $140.73. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $154.27.
Xylem Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were issued a $0.40 dividend. The ex-dividend date of this dividend was Tuesday, November 25th. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. Xylem’s dividend payout ratio is presently 41.13%.
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on the company. Cowen reiterated a “hold” rating on shares of Xylem in a research report on Friday, December 5th. Wall Street Zen downgraded Xylem from a “buy” rating to a “hold” rating in a research note on Saturday, December 27th. Citigroup upped their price target on Xylem from $173.00 to $182.00 and gave the company a “buy” rating in a research report on Wednesday, October 29th. Weiss Ratings reissued a “buy (b-)” rating on shares of Xylem in a report on Monday, December 29th. Finally, Argus set a $170.00 price objective on shares of Xylem in a research note on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company’s stock. According to MarketBeat.com, Xylem currently has a consensus rating of “Moderate Buy” and a consensus target price of $165.80.
Insider Buying and Selling at Xylem
In other news, EVP Claudia S. Toussaint sold 10,421 shares of the firm’s stock in a transaction on Thursday, October 30th. The shares were sold at an average price of $152.64, for a total transaction of $1,590,661.44. Following the sale, the executive vice president owned 31,250 shares in the company, valued at approximately $4,770,000. This trade represents a 25.01% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Victoria D. Harker sold 1,700 shares of Xylem stock in a transaction on Tuesday, November 4th. The stock was sold at an average price of $148.14, for a total transaction of $251,838.00. Following the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Company insiders own 0.27% of the company’s stock.
Xylem Profile
Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.
The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.
See Also
- Five stocks we like better than Xylem
- Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
- A U.S. “birthright” claim worth trillions – activated quietly
- Ticker Revealed: Pre-IPO Access to “Next Elon Musk” Company
- First Time Since 2007: All Warnings Active
- How the Rich Retire
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL – Free Report).
Receive News & Ratings for Xylem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Xylem and related companies with MarketBeat.com's FREE daily email newsletter.
